Perioperative Cannabis Use in Bariatric Patients: A Review of Outcomes and Proposed Clinical Pathway for Management - Takeaways - MDSpire

Perioperative Cannabis Use in Bariatric Patients: A Review of Outcomes and Proposed Clinical Pathway for Management

  • By

  • Meghan H. Maceyko

  • Marc Neff

  • Jonathan Halevy

  • Marguerite Dunham

  • May 21, 2024

  • 0 min

Share

  • 1

    Approximately 260,000 Americans underwent bariatric surgery in 2021, with 25% failing to achieve expected weight loss outcomes.

  • 2

    Substance use, including cannabis, is a significant co-morbidity in bariatric patients, with 6-8% admitting to cannabis use.

  • 3

    Current guidelines lack specific recommendations for managing cannabis use in patients undergoing bariatric surgery.

  • 4

    Cannabis use can increase peri-operative risks, including myocardial infarction and altered pulmonary function.

  • 5

    A proposed clinical pathway aims to assist clinicians in managing bariatric patients who report cannabis use.

Original Source(s)

Perioperative Cannabis Use in Bariatric Patients: A Review of Outcomes and Proposed Clinical Pathway for Management

  • by Meghan H. Maceyko, Marc Neff, Jonathan Halevy, Marguerite Dunham

  • May 21, 2024

Related Content

Tracking Opioid Refills After Surgery

Researchers evaluated perioperative and postdischarge factors associated with opioid refill prescriptions during the first 90 days after inpatient otolaryngology–head and neck surgery.

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

How Language Shapes Care 

ACP examines ethical implications of calling all physicians “providers”